Newly Approved Drug Therapies (384): Sclerosol Intrapleural Aerosol, Bryan Corporation

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Sclerosol Intrapleural Aerosol

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Bryan Corporation
Approval Status: Approved January 1998
Treatment for: malignant pleural effusions

General Information

Sclerosol Intrapleural Aerosol has been approved for the prevention of recurrence of malignant pleural effusions in symptomatic patients. Symptoms include chest pain, dyspnea, and coughing. It is to be administered by aerosol during thracoscopy or open thoracotomy.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]